Risk Management Plan: Expert Review of Applications for Marketing Authorisation in the EAEU Depending on the Type of Medicinal Product (Review)
INTRODUCTION. A risk management plan (RMP) is an important document for assessing and managing risks when using a medicinal product. An RMP is provided as part of the marketing authorisation application for a medicinal product. The requirements for the need to submit an RMP and the information in it...
Saved in:
Main Authors: | T. M. Bukatina, E. V. Shubnikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2024-07-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/438 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
by: T. M. Bukatina, et al.
Published: (2023-03-01) -
Analysis of Errors Identified during Regulatory Review of Risk Management Plans Submitted as Part of Registration Dossiers
by: A. O. Lovkova, et al.
Published: (2023-12-01) -
Risk Assessment Algorithms in Pharmacovigilance: A Review
by: T. M. Bukatina
Published: (2025-06-01) -
Critical Overview of the Contents of Risk Management Plans for Medicines
by: T. M. Bukatina, et al.
Published: (2022-04-01) -
Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU
by: G. N. Gildeeva, et al.
Published: (2019-07-01)